Maša Alečković

6.9k total citations
17 papers, 536 citations indexed

About

Maša Alečković is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Maša Alečković has authored 17 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Maša Alečković's work include Click Chemistry and Applications (4 papers), Cancer Research and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). Maša Alečković is often cited by papers focused on Click Chemistry and Applications (4 papers), Cancer Research and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). Maša Alečković collaborates with scholars based in United States, Australia and Sweden. Maša Alečković's co-authors include Yibin Kang, Kornélia Polyák, Carlos R. Gil Del Alcazar, Andrés Blanco, Yong Wei, Gary LeRoy, Carlos Simón, Sandra S. McAllister, Tuo Li and Zhen Xu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Maša Alečković

14 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maša Alečković United States	8	326	190	180	92	89	17	536
Shaokun Shu China	11	330 1.0×	208 1.1×	167 0.9×	64 0.7×	108 1.2×	18	575
Marisa Mariani United States	15	476 1.5×	249 1.3×	235 1.3×	76 0.8×	61 0.7×	24	758
Timothy A. Yap United Kingdom	8	289 0.9×	200 1.1×	111 0.6×	72 0.8×	40 0.4×	10	568
Nicole E. McNeil United States	12	312 1.0×	223 1.2×	107 0.6×	98 1.1×	106 1.2×	23	623
Hengbo Zhou United States	12	357 1.1×	268 1.4×	154 0.9×	33 0.4×	97 1.1×	18	617
Grace R. Anderson United States	11	573 1.8×	190 1.0×	210 1.2×	47 0.5×	54 0.6×	13	763
Rosanna Lacalamita Italy	15	358 1.1×	223 1.2×	233 1.3×	78 0.8×	32 0.4×	30	647
Marina Chan United States	10	331 1.0×	200 1.1×	77 0.4×	37 0.4×	46 0.5×	16	534
Melissa M. Wolf United States	7	502 1.5×	228 1.2×	306 1.7×	50 0.5×	103 1.2×	13	720
Kateřina Bouchalová Czechia	12	193 0.6×	229 1.2×	128 0.7×	48 0.5×	41 0.5×	35	486

Countries citing papers authored by Maša Alečković

Since Specialization

Citations

This map shows the geographic impact of Maša Alečković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maša Alečković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maša Alečković more than expected).

Fields of papers citing papers by Maša Alečković

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maša Alečković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maša Alečković. The network helps show where Maša Alečković may publish in the future.

Co-authorship network of co-authors of Maša Alečković

This figure shows the co-authorship network connecting the top 25 collaborators of Maša Alečković. A scholar is included among the top collaborators of Maša Alečković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maša Alečković. Maša Alečković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Srinivasan, Sangeetha, Nathan K. Yee, Maša Alečković, et al.. (2025). Development of a First-in-Class Click Chemistry–Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial. Clinical Cancer Research. 31(17). 3662–3677.

Alečković, Maša, Sangeetha Srinivasan, Jesse M. McFarland, et al.. (2025). Abstract 342: First-in-class click chemistry-based pre-targeting of CEACAM5 tumor antigen selectively activates an MMAE payload at tumors. Cancer Research. 85(8_Supplement_1). 342–342.

Bui, Nam Q., Vineet Kwatra, Christopher W. Ryan, et al.. (2024). Phase 2a results of SQ3370, a doxorubicin-based click chemistry therapeutic in patients with advanced STS: Planned interim analysis.. Journal of Clinical Oncology. 42(16_suppl). 11555–11555. 2 indexed citations

Alečković, Maša, Zheqi Li, Xintao Qiu, et al.. (2023). Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer. Molecular Cancer Therapeutics. 22(11). 1304–1318. 6 indexed citations

McFarland, Jesse M., et al.. (2023). Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents. ACS Central Science. 9(7). 1400–1408. 30 indexed citations

Chawla, Sant P., Maša Alečković, Vivek A. Bhadri, et al.. (2022). Interim phase 1 results for SQ3370 in advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 3085–3085. 2 indexed citations

Alečković, Maša, et al.. (2022). 954 SQ2270, a novel MMAE-based therapeutic, promotes tumor growth inhibition and extensive immune cell infiltration in the RENCA cancer model. Regular and Young Investigator Award Abstracts. A996–A996. 1 indexed citations

Alcazar, Carlos R. Gil Del, Maša Alečković, & Kornélia Polyák. (2020). Immune Escape during Breast Tumor Progression. Cancer Immunology Research. 8(4). 422–427. 83 indexed citations

Alečković, Maša, Sandra S. McAllister, & Kornélia Polyák. (2019). Metastasis as a systemic disease: molecular insights and clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1872(1). 89–102. 47 indexed citations

10.

Alečković, Maša, Yong Wei, Gary LeRoy, et al.. (2017). Identification of Nidogen 1 as a lung metastasis protein through secretome analysis. Genes & Development. 31(14). 1439–1455. 49 indexed citations

11.

Alečković, Maša. (2016). The Role of Secreted Proteins and Exosomes in Cancer Metastasis. 1 indexed citations

12.

Alečković, Maša & Yibin Kang. (2015). Bone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasis. BoneKEy Reports. 4. 671–671. 7 indexed citations

13.

Alečković, Maša & Yibin Kang. (2014). Regulation of cancer metastasis by cell-free miRNAs. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1855(1). 24–42. 87 indexed citations

14.

Blanco, Andrés, Gary LeRoy, Zia Khan, et al.. (2012). Global secretome analysis identifies novel mediators of bone metastasis. Cell Research. 22(9). 1339–1355. 84 indexed citations

15.

Blanco, Andrés, Maša Alečković, Tuo Li, et al.. (2011). Identification of Staphylococcal Nuclease Domain-containing 1 (SND1) as a Metadherin-interacting Protein with Metastasis-promoting Functions. Journal of Biological Chemistry. 286(22). 19982–19992. 102 indexed citations

16.

Alečković, Maša & Carlos Simón. (2008). Is teratoma formation in stem cell research a characterization tool or a window to developmental biology?. Reproductive BioMedicine Online. 17(2). 270–280. 34 indexed citations

17.

Alečković, Maša & David Carter. (2008). RNAi at Oxford.. PubMed. 4(1). 266–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact